GORDON KEVIN K 4
4 · VERACYTE, INC. · Filed Jan 5, 2021
Insider Transaction Report
Form 4
VERACYTE, INC.VCYT
GORDON KEVIN K
Director
Transactions
- Exercise/Conversion
Common Stock
2021-01-04$7.39/sh+10,000$73,900→ 10,000 total - Sale
Common Stock
2021-01-04$48.62/sh−4,477$217,664→ 5,523 total - Sale
Common Stock
2021-01-04$49.27/sh−5,523$272,134→ 0 total - Exercise/Conversion
Stock Option (right to buy)
2021-01-04−10,000→ 15,000 totalExercise: $7.39Exp: 2026-12-11→ Common Stock (10,000 underlying)
Footnotes (4)
- [F1]The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on September 1, 2020.
- [F2]Represents weighted average sales price. Sale prices for the transactions range from $48.02 to $49.00. Detailed information regarding the number of shares sold at each separate price will be provided to the SEC, the issuer or a shareholder upon request.
- [F3]Represents weighted average sales price. Sale prices for the transactions range from $49.04 to $49.56. Detailed information regarding the number of shares sold at each separate price will be provided to the SEC, the issuer or a shareholder upon request.
- [F4]The option is fully vested.